Optimas Capital Partners Fund
6
35M
6
1
1
- Stages of investment
- Areas of investment
Summary
We can highlight the next thriving fund investment areas, such as Virtual Reality, Health Diagnostics. The fund has exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight WaveOptics, Ceribell. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
The fund is generally included in less than 2 deals every year. The top activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the Optimas Capital Partners Fund, startups are often financed by Robert Bosch Venture Capital, Touchstone Innovations, Pitch@Palace. The meaningful sponsors for the fund in investment in the same round are UCB Pharma, The Rise Fund, Robert Bosch Venture Capital. In the next rounds fund is usually obtained by Robert Bosch Venture Capital, Octopus Ventures, IP Group Plc.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 1
- Exits
- 1
- Investments by industry
- Augmented Reality (2)
- Health Care (2)
- Biotechnology (2)
- Construction (1)
- Hardware (1) Show 15 more
- Investments by region
-
- Singapore (1)
- United Kingdom (2)
- United States (1)
- China (2)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 85M
- Group Appearance index
- 1.00
- Avg. company exit year
- 7
- Avg. multiplicator
- 8.69
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Nutshell Therapeutics | 01 Dec 2020 | Health Care, Product Research | Seed | 15M | Shanghai, Huangpu, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.